https://justusrhope.substack.com/p/a-new-ivermectinmebendazole-cocktail?
A New Ivermectin/Mebendazole Cocktail for Cancer Treatment
Announcing the RESET-5™ Protocol

Article Excerpts:
Resistance to chemotherapy and radiation is a well-documented challenge in oncology. Clinicians have increasingly reported that resistance can also emerge even when core repurposed drug metabolic cocktails are added to standard treatment regimens.
The Care Oncology Clinic’s 4-Drug COC Protocol — comprising Doxycycline, Atorvastatin, Mebendazole, and Metformin — represents a strong foundational approach to metabolic cancer therapy. In the METRICS trial, adding this protocol to standard of care in Glioblastoma was associated with nearly a one-year increase in survival.
The Problem of Resistance in Metabolic Protocols
Despite these promising results, resistance to the COC Protocol has been reported as well. The core problem lies in the nature of Cancer Stem Cells (CSCs): these cells are remarkably adaptable. When placed under primarily metabolic pressure, CSCs exploit alternative fuel sources and, given enough time, appear to reliably escape any single-axis metabolic attack.
Building a more powerful, resistance-prevention protocol requires a broader strategy — one that targets far more than cancer’s metabolism alone.
The RESET-5™ Protocol (Redox, Epigenetic, and Stem-cell Eradication Therapy)
Why it works:
The word “reset” profoundly captures what this protocol does compared to COC. While COC essentially attempts to starve the tumor, this protocol chemically resets the cancer’s mutated epigenome (via SFN), resets the gut microbiome (via AGE), and eradicates the root stem cells.
- The RESET-5 Protocol (Mebendazole, Ivermectin, Sulforaphane, Metformin, Aged Garlic Extract) represents a significant improvement over the traditional 4-drug Care Oncology Clinic (COC) protocol (Doxycycline, Atorvastatin, Metformin, Mebendazole).
- While the COC protocol relies on broad metabolic starvation and mitochondrial toxicity, the RESET-5 protocol systematically targets cancer stem cell (CSC) networks, reverses epigenetic mutations, and modulates the redox environment without destroying the host’s immune system or microbiome.
(See link for article and charts)
For more:
- https://madisonarealymesupportgroup.com/2024/10/23/alternative-cancer-treatments-18-proven-interventions/
- https://madisonarealymesupportgroup.com/2026/01/12/reduce-cancer-risk-by-90-using-evidence-based-natural-compounds/
- https://madisonarealymesupportgroup.com/2025/02/20/the-remarkable-anti-cancer-potential-of-mushrooms/
- https://madisonarealymesupportgroup.com/2024/10/15/first-cancer-protocol-using-ivermectin-mebendazole-and-fenbendazole-published/
- https://madisonarealymesupportgroup.com/2019/11/15/antiparasitic-antifungl-medications-targeting-cancer-cells-repurposing-drugs-for-cancer/
- https://madisonarealymesupportgroup.com/2025/03/07/metabolic-therapies-reclaiming-cancers-achilles-heel-through-the-ivermectin-fenben-and-allulose-revolution/
- https://madisonarealymesupportgroup.com/2026/01/05/preventing-cancer-the-root-protocols/
- https://madisonarealymesupportgroup.com/2025/08/05/cancer-is-reversible-prof-flavins-50-years-of-research/
- https://madisonarealymesupportgroup.com/2025/11/03/tenenbaum-cancer-protocol/
- https://madisonarealymesupportgroup.com/2025/09/03/highlights-how-fenben-and-meben-disrupt-cancer-pathways/ Within link is an interview with Professor Thomas N. Seyfried, PhD whom was so instrumental to Tenenbaum’s treatment.
- https://madisonarealymesupportgroup.com/2025/02/07/cancer-disappeared/
- https://madisonarealymesupportgroup.com/2024/02/06/cancer-ms-repurposed-drugs/